| Ginkgo Bioworks Hldgs Inc (DNA) | |||
|---|---|---|---|
| 9.71 -0.3 (-3%) | 10-22 16:00 | ||
| Open: | 9.69 | Pre. Close: | 10.01 |
| High: | 10.14 | Low: | 9.5 |
| Volume: | 1,978,882 | Market Cap: | 654(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 16.50  One year: 21.28 |
| Support: | Support1: 7.49 Support2: 6.24 |
| Resistance: | Resistance1: 14.12 Resistance2: 18.22 |
| Pivot: | 11.49  |
| Moving Averages: | MA(5): 9.98 MA(20): 11.54 MA(100): 8.84 MA(250): 8.70 |
| MACD: | MACD(12,26): 0.24 Signal(12,26,9): 0.67 |
| %K %D: | %K(14,3): 2.74 %D(3): 2.74 |
| RSI: | RSI(14): 45.53 |
| 52-Week: | High: 18.22 Low: 5.37 Change(%): -26.5 |
| Average Vol(K): | 3-Month: 2149 10-Days: 2531 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 10.169 - 10.225 | 10.225 - 10.271 |
| Low: | 9.333 - 9.409 | 9.409 - 9.472 |
| Close: | 9.595 - 9.711 | 9.711 - 9.805 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ DNA ] has closed above bottom band by 17.4%. Bollinger Bands are 71% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue. |
| Company profile |
|---|
| Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Underperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 55.38 |
| Shares Float (M) | 49.88 |
| % Held by Insiders | 4.43 |
| % Held by Institutions | 73.70 |
| Shares Short (K) | 7320 |
| Shares Short Prior Month (K) | 6870 |
| Stock Financials | |
|---|---|
| EPS | -5.060 |
| Book Value (p.s.) | 6.600 |
| Profit Margin | -219.60 |
| Operating Margin | -284.99 |
| Return on Assets (ttm) | -16.7 |
| Return on Equity (ttm) | -59.9 |
| Qtrly Rev. Growth | -48.5 |
| Gross Profit (p.s.) | 1.627 |
| Sales Per Share | 2.391 |
| EBITDA (p.s.) | -4.724 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -170.24 |
| Levered Free Cash Flow (M) | -72.40 |
| Stock Valuation | |
|---|---|
| PE Ratio | -1.92 |
| PEG Ratio | |
| Price to Book value | 1.47 |
| Price to Sales | 4.06 |
| Price to Cash Flow | -3.16 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
